Asia-Pacific Americas Africa Europe Middle East

LAURUS LABS LTD UNIT 3.

Company Profile:

Company Enterprise Introduction:

Laurus Labs Ltd is a prominent research and development driven pharmaceutical company based in India. The company specializes in the development, manufacturing, and sale of Active Pharmaceutical Ingredients (APIs), intermediates, and generic finished dosage forms (FDFs) across diverse therapeutic areas including anti-retrovirals, hepatitis C, oncology, and other therapeutic areas. Laurus Labs also provides contract development and manufacturing services (CDMO) to global pharmaceutical companies. Unit 3 specifically refers to one of their dedicated manufacturing facilities, involved in the production of pharmaceutical products.

Factory or Trader:

Factory (Manufacturer)

Enterprise Products

Laurus Labs Ltd Unit 3, located in India, primarily manufactures Active Pharmaceutical Ingredients (APIs) and intermediates. These products cater to various therapeutic areas, contributing to Laurus Labs' overall portfolio.

The products manufactured or sold, directly or indirectly supported by operations at Unit 3, include:

Active Pharmaceutical Ingredients (APIs) for:

Antiretrovirals (ARVs)

Oncology

Anti-diabetics

Cardiovascular diseases

Proton Pump Inhibitors (PPIs)

Other high-growth therapeutic areas

Pharmaceutical intermediates for the production of these APIs.

The unit also supports custom synthesis and contract manufacturing services for global pharmaceutical and biotech companies.

Business Registration Information:

Manager:

Not publicly disclosed for this specific unit.

Phone:

+91 40 3980 4300

E-mail:

investor@lauruslabs.com

Official Website:
Address:

Plot No. 21, Jawaharlal Nehru Pharma City (JNPC), Parawada, Visakhapatnam - 531019, Andhra Pradesh, India.

This content is from AI, the data and information provided is for reference only and is not applicable to investment and purchase decisions. If there is any incorrect information, please contact customer service to correct it.